HIV/AIDS refers to infection with human immunodeficiency virus and its advanced stage, acquired immunodeficiency syndrome. HIV progressively weakens immune defenses, and without treatment may progress to severe immunodeficiency with opportunistic infections and malignancies. Antiretroviral therapy can suppress the virus and prevent progression to AIDS.
South Africa will begin providing lenacapavir on June 5 after delays tied to postimportation testing, while Uganda has launched rollout of the twice-yearly HIV prevention injection in Lira.
Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.
GLP-1 drugs discovered accidentally in anglerfish research now treat conditions beyond diabetes including kidney disease, sleep apnea, and addiction. The global diabetes therapeutics market is projected to reach $241.5 billion by 2030, growing at 12.4% annually.
The National Institute of Allergy and Infectious Diseases has been instructed to remove "biodefense" and "pandemic preparedness" language from its website, signaling a major shift away from these research priorities. NIH leadership says the institute will now focus on current infectious diseases and basic immunology rather than predicting future threats. Public health experts warn this could leave the U.S. less prepared for future health emergencies.
Zimbabwe began rolling out lenacapavir, a twice-yearly injectable HIV prevention drug, on February 19 in Epworth. The program will initially target more than 46,000 people at high risk across 24 sites nationwide.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07298785 |
Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot Study |
RECRUITING | NA |
| NCT07203261 |
Comparison of the Body Roundness Index and A Body Shape Index With Body Fat and Visceral Fat in People Living With HIV. |
NOT_YET_RECRUITING | |
| NCT07091253 |
Physical Activity and People Living With HIV in New York City |
TERMINATED | |
| NCT07074899 |
Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru |
ACTIVE_NOT_RECRUITING | NA |
| NCT07072481 |
Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing |
RECRUITING | NA |
| NCT07064785 |
Video-Intervention to Inspire Treatment Adherence for Life for Adolescents |
ACTIVE_NOT_RECRUITING | NA |
| NCT06952582 |
Promoting Safer Sexual Dual Protection Behaviors for Female University Students to Reduce Risks of Both STI/HIV and Unintended Pregnancy |
COMPLETED | NA |
| NCT06949774 |
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) |
RECRUITING | NA |
| NCT06741631 |
MyPEEPS LITE Trial |
RECRUITING | NA |
| NCT06741618 |
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM |
RECRUITING | NA |
